Welcome to BioMarket Group!

Immunomodulators

In this section you will find Therapeutics Line of Treatment Immunomodulators market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

6 Item(s)

per page

Set Ascending Direction
  1. Immunotherapy in Oncology Drug Pipeline Update

    $3,675.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 830 companies plus partners who are today developing 1578 cancer immunotherapy drugs in 4062 developmental projects in cancer across 535 different targets. In addition, there are 19 suspended drugs and another 624 drugs where development has been ceased. Learn More

  2. Antibodies in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 542 companies plus partners who are today developing 1308 antibody drugs in 3051 developmental projects in cancer across 414 different targets. In addition, there are 4 suspended drugs and another 407 drugs where development has been ceased. Learn More

  3. Cytokine Therapy in Oncology Drug Pipeline Update

    $1,495.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 80 companies plus partners who are today developing 99 cytokine drugs in 195 developmental projects in cancer across 20 different targets. In addition, there is 1 suspended drug and another 11 drugs where development has been ceased. Learn More

  4. Cancer Vaccines Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 314 companies plus partners who are today developing 386 cancer vaccine drugs in 784 developmental projects in cancer across 195 different targets. In addition, there are 8 suspended drugs and another 208 drugs where development has been ceased. Learn More

  5. Analytical Tool - Antibodies in Oncology

    $3,750.00
    Published by BioSeeker Group on Jan 12th, 2015
    Premium analysis tool on the commercial development of antibodies in oncology. This unique tool integrates system biology into traditional business information in order to achieve best practice when it comes to analyzing and understand targeted therapy and personalized medicine of antibodies in oncology. Learn More

  6. Analytical Tool - Cancer Immunotherapy

    $8,175.00
    Published by BioSeeker Group on Mar 25th, 2014
    A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer immunotherapy. Learn More

6 Item(s)

per page

Set Ascending Direction

Immunomodulators

In this section you will find Therapeutics Line of Treatment Immunomodulators market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

6 Item(s)

per page

Set Ascending Direction
  1. Immunotherapy in Oncology Drug Pipeline Update

    $3,675.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 830 companies plus partners who are today developing 1578 cancer immunotherapy drugs in 4062 developmental projects in cancer across 535 different targets. In addition, there are 19 suspended drugs and another 624 drugs where development has been ceased. Learn More

  2. Antibodies in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 542 companies plus partners who are today developing 1308 antibody drugs in 3051 developmental projects in cancer across 414 different targets. In addition, there are 4 suspended drugs and another 407 drugs where development has been ceased. Learn More

  3. Cytokine Therapy in Oncology Drug Pipeline Update

    $1,495.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 80 companies plus partners who are today developing 99 cytokine drugs in 195 developmental projects in cancer across 20 different targets. In addition, there is 1 suspended drug and another 11 drugs where development has been ceased. Learn More

  4. Cancer Vaccines Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 314 companies plus partners who are today developing 386 cancer vaccine drugs in 784 developmental projects in cancer across 195 different targets. In addition, there are 8 suspended drugs and another 208 drugs where development has been ceased. Learn More

  5. Analytical Tool - Antibodies in Oncology

    $3,750.00
    Published by BioSeeker Group on Jan 12th, 2015
    Premium analysis tool on the commercial development of antibodies in oncology. This unique tool integrates system biology into traditional business information in order to achieve best practice when it comes to analyzing and understand targeted therapy and personalized medicine of antibodies in oncology. Learn More

  6. Analytical Tool - Cancer Immunotherapy

    $8,175.00
    Published by BioSeeker Group on Mar 25th, 2014
    A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer immunotherapy. Learn More

6 Item(s)

per page

Set Ascending Direction